JPRN-UMIN000047001已完成未知
Objective response, disease control rate, and progression-free survival, as surrogates of overall survival in trials evaluating immune checkpoint inhibitor regimens for advanced non-small cell lung cancer: individual-patient-data and study-level analyses - Objective response, disease control rate, and progression-free survival, as surrogates of overall survival in trials evaluating immune checkpoint inhibitor regimens for advanced non-small cell lung cancer: individual-patient-data and study-level analyses
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 3,312
研究概览
简要总结
See below: N Horita. Tumor Response, Disease Control, and Progression-Free Survival as Surrogate Endpoints in Trials Evaluating Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: Study- and Patient-Level Analyses. Cancers (Basel). 2023 Jan; 15(1): 185.
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •[Independent-patient-level analysis part] Not defined. [Study-level analysis part] Non-English article and conference abstract.
研究者
相似试验
招募中
不适用
Tumor Control, Treatment Toxicity, Quality of Life and Bio-Imaging Repository Databank (TQ-BIRD) for Cancer PatientsCancerNCT05061342Fengming Kong5,000
已完成
不适用
Correlation with overall survival of response rate (RR) and disease control rate (DCR) in phase II randomized controlled trials evaluating second- or later-line chemotherapy for advanced, locally advanced, and recurrent non-small cell lung cancer.SCLCJPRN-UMIN000040412Yokohama City University9,059
已完成
2 期
Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)Renal Cell Carcinoma, MetastaticNCT02432846Mendus88
Unknown
不适用
Neoadjuvant Immune Checkpoint Inhibitor Combined With Chemotherapy in Non-small Cell Lung CancerNon-small Cell Lung CancerNCT04945200Second Affiliated Hospital, School of Medicine, Zhejiang University50
已完成
不适用
Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life DatabasesMetastatic Breast CancerNCT03676257Institut Bergonié20,033